Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.10/555
Título: Recent advances in antiretroviral treatment and prevention in HIV-infected patients
Autor: Maltez, F
Doroana, M
Branco, T
Valente, C
Palavras-chave: Infecção por HIV
HIV infections
Antiretrovirais
Antiretroviral therapy
Data: 2011
Editora: Lippincott Williams & Wilkins
Citação: Curr Opin HIV AIDS. 2011 Dec;6 Suppl 1:S21-30.
Resumo: PURPOSE OF REVIEW: To discuss new antiretroviral agents (ARVs) and alternative ARV treatment strategies that are currently being evaluated, and to provide an overview of the most recent advances in HIV vaccine development. RECENT FINDINGS: There is a continuous need for improvements in ARV therapy (ART) and several new ARVs are currently undergoing clinical investigation, including the non-nucleoside reverse transcriptase inhibitor rilpivirine, the integrase inhibitor elvitegravir, the chemokine receptor 5 co-receptor antagonist vicriviroc and the maturation inhibitor bevirimat. Strategies to optimize ART, such as treatment interruption, induction-maintenance and class-sparing regimens, are also being evaluated and have had varying success to date. However, vaccination still remains the optimal solution, and one second-generation preventative HIV vaccine has produced encouraging results in a recent phase III trial. SUMMARY: Global prevention and treatment with ARVs that are effective, well tolerated and have high barriers to the development of HIV resistance are the main strategies to fight HIV/AIDS while we await the development of an effective vaccine.
Peer review: yes
URI: http://hdl.handle.net/10400.10/555
ISSN: 1746-630X
Aparece nas colecções:INF - Artigos

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Curr Opin HIV AIDS. 2011 Dec, 6 Suppl 1S21-30.PDF8,95 MBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.